beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).
Tomás Herraiz, D González, C Ancín-Azpilicueta, Vicente J Arán, Hugo Guillén
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association March 1, 2010 DOI: 10.1016/j.fct.2009.12.019 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Laboratory study Peer reviewed |
|---|---|
| Population | Peganum harmala plant extracts |
| Key points | Seed and root extracts of Peganum harmala are potent, reversible, competitive inhibitors of human MAO-A, with seed extracts (IC50 27 µg/L) more potent than root extracts (IC50 159 µg/L), while stem and leaf extracts are poor inhibitors. |
Abstract
Peganum harmala L. is a multipurpose medicinal plant increasingly used for psychoactive recreational purposes (Ayahuasca analog). Harmaline, harmine, harmalol, harmol and tetrahydroharmine were identified and quantified as the main beta-carboline alkaloids in P. harmala extracts. Seeds and roots contained the highest levels of alkaloids with low levels in stems and leaves, and absence in flowers. Harmine and harmaline accumulated in dry seeds at 4.3% and 5.6% (w/w), respectively, harmalol at 0.6%, and tetrahydroharmine at 0.1% (w/w). Roots contained harmine and harmol with 2.0% and 1.4% (w/w), respectively. Seed extracts were potent reversible and competitive inhibitors of human monoamine oxidase (MAO-A) with an IC(50) of 27 microg/l whereas root extracts strongly inhibited MAO-A with an IC(50) of 159 microg/l. In contrast, they were poor inhibitors of MAO-B. Inhibition of MAO-A by seed extracts was quantitatively attributed to harmaline and harmine whereas inhibition by root extracts came from harmine with no additional interferences. Stems and leaves extracts were poor inhibitors of MAO. The potent inhibition of MAO-A by seed and root extracts of P. harmala containing beta-carbolines should contribute to the psychopharmacological and toxicological effects of this plant and could be the basis for its purported antidepressant actions.
Citations in the library
Cited by 38
- Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review 2013
- The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology March 2, 2016
- Ayahuasca: Pharmacology, neuroscience and therapeutic potential Brain Research Bulletin March 11, 2016
- Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness Current Neuropharmacology March 2, 2018
- Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Current Drug Metabolism October 1, 2010
and 33 more in the library
Cites 9
- Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics May 1, 2004
- Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine Journal of Psychoactive Drugs April 1, 1999
- Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. Journal of Toxicology Clinical Toxicology 2004
- A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Science International August 6, 2008
- Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis. Journal of Psychoactive Drugs June 1, 2005
and 4 more in the library